> West ($WST), a maker of products for injected drugs, has teamed up drug-delivery specialist Vetter to make filled Daikyo Crystal Zenith syringes. Release
> Johnson & Johnson ($JNJ) has asked the FDA to approved its extended-release Nucynta (tapentadol) tablets for pain from diabetic peripheral neuropathy. Release
> Depomed ($DEPO), a developer and provider of extended-release drugs, reported a net loss of $8.6 million in the third quarter, compared with net income of $1.9 million for the same period last year. Release
> Oxford Pharmascience, a developer of new formulations of generic drugs, has raised more than £1.1 million to fund its programs and its business in Brazil. Article
> Halozyme ($HALO) provided upbeat data from an early trial of its fast-acting drug tech used with insulin in patients with type 1 diabetes. Release